Compare HIND & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIND | GENK |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | 18 | 2700 |
| Industry | | Restaurants |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 12.8M |
| IPO Year | 2016 | 2023 |
| Metric | HIND | GENK |
|---|---|---|
| Price | $2.23 | $1.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $15.00 | $4.50 |
| AVG Volume (30 Days) | ★ 15.4K | 13.2K |
| Earning Date | 05-20-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | N/A | ★ 62.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $208,380,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | $7.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.12 |
| 52 Week Low | $1.75 | $1.43 |
| 52 Week High | $12.87 | $4.98 |
| Indicator | HIND | GENK |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 38.76 |
| Support Level | $1.99 | $1.72 |
| Resistance Level | $2.33 | $2.18 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 43.70 | 9.30 |
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.